Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH) (ATOLL)

This study has been completed.
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris Identifier:
First received: July 16, 2008
Last updated: December 17, 2012
Last verified: December 2012